Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending Topics
Clinical Development
Biologics
Fierce 50
Special Report
Awards Gala
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Trending T
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending Topics
Clinical Development
Biologics
Fierce 50
Special Report
Awards Gala
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Omeros
Biotech
Omeros stops kidney disease phase 3 after interim review fail
Omeros stopped a phase 3 trial of narsoplimab in kidney disease patients after an interim analysis found it was destined to fail.
Nick Paul Taylor
Oct 16, 2023 8:45am
Omeros saddles up for 2nd charge at transplant drug approval
Mar 14, 2023 9:30am
Omeros' Hail Mary throw for blood clot med delayed at FDA
Aug 17, 2022 11:21am
FDA rejects Omeros drug over difficulties estimating its effect
Oct 18, 2021 8:15am
Omeros hits endpoint in pivotal stem cell transplant study
Dec 4, 2019 8:38am
Chutes & Ladders—Cell Medica names Kite's European chief as CEO
Aug 3, 2018 9:43am
